Olga Yanvoskaya | International Sales & Marketing
Former executive with Covidien/Medtronic.
Glenn Brunner | Quality Assurance
President, CEO Medical Device Engineer of large to early-stage medical device companies Medex (Smiths Medical), Opticon Medical, (Bard BD), Wiseology LLC.
Board of Directors
Jay Golding | Chairman
Founder, CEO Hi-Port Industries, Falcon Seaboard, Golding Brothers Partners. Director of Benchmark Hospitality and other private companies
John P. Kennedy | Director
Founder of Kennedy Partners LLC, specializing in public-private partnerships. Former partner of Crabbe, Brown & James, former Court of Appeals Judge, Ohio, 10th District.
Peter Allen | Director
Industry veteran led Becton Dickinson IV catheter business, EVP for Vizient, the worlds largest GPO.
Raymond K. Houck | Director
Current CEO of Aclipse Therapeutics, Former CEO & Co-Founder of Thar Pharmaceuticals, Automated Cell and SuprexCorporation.
Henry Haimsohn | Director
Served in a number of positions at Handyman of California a subsidiary of Edison Brothers Stores. Founded the Pace Membership Warehouse as its Chairman and CEO.
Shawn Langer | Director
Brings over two decades of healthcare industry experience, and served as a Senior Partner at McKinsey & Company as the leader of its Healthcare Private Equity Group.
Chief Advisors
Paul Savage, PhD | Science and Chemistry
Professor of Chemistry BYU, Inventor of Ceragenin class of compounds. Author of >175 peer reviewed journal articles.
Ronald Bracken | Coatings and Operations
Industry veteran, Former VP of R&D at CR Bard leading antimicrobial device coatings.
Michael Niederman | Critical Care Medicine
Associate Chief & Clinical Dir of Pulmonary and Critical Care Medicine at Weill Cornell. Wrote guidelines for treatment of Nosocomial Pneumonia.
David Perlin, PhD | Medical Research
Highly accomplished medical researcher. Chief Scientific Officer and SVP for Hackensack Meridian Health Center for discover and innovation.
Jorge Hildago, M.D. | Critical Care Medicine
Professor of Critical Care at Karl Heuser Memorial in Belize. Secretary General of World Federation of Societies of Critical Care and Intensive Care Medicine.
Lisa Dwyer | Regulatory Strategy
Partner at King & Spalding. Specialization in FDA and Life Science. 20 years developing regulatory and legislative solutions.
Don Boyer | Canadian Regulatory
30 years experience as an expert regulatory consultant to the health products industry. Former head of Health Canada medical device department.
John Doucet | Regulatory Strategy
Former US Food and Drug Administration (FDA) Policy Lead, for the Breakthrough Device Program.
Matthew Reed, PhD | Toxicology with Expertise in Cystic Fibrosis
Dr. Reed is a pharmacologist, board certified toxicologist, past ABT Board Member, and Fellow of the Academy of Toxicology Sciences (ATS). He has a close relationship with the Cystic Fibrosis Therapeutics Foundation.
Michelle Higgin, PhD | Program Leadership
Aggressive program management, preclinical pharmacology, nonclinical, regulatory, and early phase clinical trials. Michelle has opened 40+ INDs/IMPDs/CTAs/NDAs in US, Europe, and Australia.
Dale Christensen, PhD | Clinical Development
Experience managing pre-clinical discovery and pharmacology efforts across respiratory, inflammation, CNS, anti-infective, and oncology indications.
Tom Richardson, PhD | Science and Chemistry
Over 30 years of experience in formulation, drug delivery technologies and drug product manufacturing.
Jeffrey Wang, M.D. | Toxicology with Expertise in Cystic Fibrosis
Professor of Orthopedic Surgery and Neurosurgery at USC. Chief of USC Orthopedic Spine Services, Keck School of Medicine.
Michael John | Regulatory Strategy
Chief of the Interventional Cardiology Devices Branch in the Division of Cardiovascular Devices at the US Food and Drug Administration.
Georg Wieselthaler, M.D. | SBIR Consultant – Cardiology KOL
UCSF’s director and surgical chief of Cardiac Transplantation and Mechanical Circulatory Support.
Prabir Roy-Chaudhury, M.D. | SBIR Consultant – Kidney KOL
Professor of Medicine UNC Kidney Center, Division of Nephology and Hypertension. Main research in uremic vascular biology.
